H79TI087740
Project Grant
Overview
Grant Description
North Dakota State Opioid Response Grant - The purpose of North Dakota's State Opioid Response (SOR) grant is to address the opioid overdose crisis by increasing access to FDA-approved medications for the treatment of opioid use disorder (MOUD), and for supporting the continuum of prevention, harm reduction, treatment, and recovery support services for opioid use disorder (OUD) and other concurrent substance use disorders.
The North Dakota Department of Health & Human Services’ Behavioral Health Division (BHD) plans to approach this by enhancing services and capacity statewide and community-specific, while also focusing on several priority areas.
Statewide, the number of drug overdose deaths increased from 76 in 2019 to 136 in 2022, decreasing to 114 in 2023 (ND Health Statistics and Performance).
In 2023, 67% of the overdose deaths involved an opiate and more specifically, 62% of the overdose deaths involved fentanyl.
The percentage of individuals receiving treatment through the public behavioral health system or reimbursed through the state’s substance use disorder (SUD) voucher program who report use of opioids range from 3% to 28% (ND TEDS [2023], ND SUD Voucher Active Clients [2023]).
There are four licensed opioid treatment programs (OTPs) in the state and the combined census increased from 802 in May 2022 to 1,100 in May 2023 (ND Central Registry).
To accomplish the first goal to prevent substance (mis)use with a specific focus on opioids and stimulants, the following, summarized objectives were identified:
(1) Increase the reach of messaging for "Parents Lead" and “Opioids: Take Care, Be Aware” to nearly 588,500 North Dakotans;
(2) Deepen the impact of the One Program by screening at least 3,000 individuals at participating pharmacies; and
(3) Provide education on medication safety to at least 15,000 school-aged and transitional-aged youth.
To accomplish the second goal to reduce harm related to opioids and stimulants, the following, summarized objectives were identified:
(1) Establish at least one new syringe service program; and
(2) Disseminate at least 23,350 naloxone kits to individuals most likely to witness an overdose and in locations where they are most likely to occur.
To accomplish the third goal to improve access to evidence-based treatment, the following, summarized objectives were identified:
(1) Integrate MOUD in at least 3 additional healthcare settings; and
(2) Integrate MOUD in at least 2 county correctional settings.
To accomplish the final goal to increase access to recovery support services, the following, summarized objective was identified:
(1) Integrate peer support specialists in at least 3 new settings/service.
The BHD will partner with the state’s Health Equity Office (HEO) to address the needs of diverse populations throughout all efforts in order to accomplish all SOR program goals and objectives.
The BHD will review the state’s SOR proposed strategies with the HEO to ensure strategies and activities will promote behavioral health equity.
The BHD has a long-standing history of partnering with North Dakota tribes on behavioral health initiatives.
The BHD has specifically offered funding and resources to the four tribal nations in the state with previous iterations of the SOR grant and will continue to do so with the upcoming SOR award.
Tribal nations in the state will be able to apply for funds to implement strategies aligning to the statewide SOR plan and also taking into consideration local needs and cultural differences.
The North Dakota Department of Health & Human Services’ Behavioral Health Division (BHD) plans to approach this by enhancing services and capacity statewide and community-specific, while also focusing on several priority areas.
Statewide, the number of drug overdose deaths increased from 76 in 2019 to 136 in 2022, decreasing to 114 in 2023 (ND Health Statistics and Performance).
In 2023, 67% of the overdose deaths involved an opiate and more specifically, 62% of the overdose deaths involved fentanyl.
The percentage of individuals receiving treatment through the public behavioral health system or reimbursed through the state’s substance use disorder (SUD) voucher program who report use of opioids range from 3% to 28% (ND TEDS [2023], ND SUD Voucher Active Clients [2023]).
There are four licensed opioid treatment programs (OTPs) in the state and the combined census increased from 802 in May 2022 to 1,100 in May 2023 (ND Central Registry).
To accomplish the first goal to prevent substance (mis)use with a specific focus on opioids and stimulants, the following, summarized objectives were identified:
(1) Increase the reach of messaging for "Parents Lead" and “Opioids: Take Care, Be Aware” to nearly 588,500 North Dakotans;
(2) Deepen the impact of the One Program by screening at least 3,000 individuals at participating pharmacies; and
(3) Provide education on medication safety to at least 15,000 school-aged and transitional-aged youth.
To accomplish the second goal to reduce harm related to opioids and stimulants, the following, summarized objectives were identified:
(1) Establish at least one new syringe service program; and
(2) Disseminate at least 23,350 naloxone kits to individuals most likely to witness an overdose and in locations where they are most likely to occur.
To accomplish the third goal to improve access to evidence-based treatment, the following, summarized objectives were identified:
(1) Integrate MOUD in at least 3 additional healthcare settings; and
(2) Integrate MOUD in at least 2 county correctional settings.
To accomplish the final goal to increase access to recovery support services, the following, summarized objective was identified:
(1) Integrate peer support specialists in at least 3 new settings/service.
The BHD will partner with the state’s Health Equity Office (HEO) to address the needs of diverse populations throughout all efforts in order to accomplish all SOR program goals and objectives.
The BHD will review the state’s SOR proposed strategies with the HEO to ensure strategies and activities will promote behavioral health equity.
The BHD has a long-standing history of partnering with North Dakota tribes on behavioral health initiatives.
The BHD has specifically offered funding and resources to the four tribal nations in the state with previous iterations of the SOR grant and will continue to do so with the upcoming SOR award.
Tribal nations in the state will be able to apply for funds to implement strategies aligning to the statewide SOR plan and also taking into consideration local needs and cultural differences.
Funding Goals
ADDRESSING THE OPIOID ABUSE CRISIS WITHIN SUCH STATES, USED FOR CARRYING OUT ACTIVITIES THAT SUPPLEMENT ACTIVITIES PERTAINING TO OPIOIDS UNDERTAKEN BY THE STATE AGENCY RESPONSIBLE FOR ADMINISTERING THE SUBSTANCE ABUSE PREVENTION AND TREATMENT BLOCK GRANT UNDER SUBPART II OF PART B OF TITLE XIX OF THE PUBLIC HEALTH SERVICE ACT (42 U.S.C. 300X21 ET SEQ.), AND TRIBES AND TRIBAL ORGANIZATIONS TO ADDRESS THE OPIOID CRISIS WITHIN THEIR COMMUNITIES.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
North Dakota
United States
Geographic Scope
State-Wide
Related Opportunity
North Dakota Department Of Human Services was awarded
North Dakota Opioid Response : Enhancing Access Support Services
Project Grant H79TI087740
worth $4,000,000
from the Division of Grants Management in September 2024 with work to be completed primarily in North Dakota United States.
The grant
has a duration of 3 years and
was awarded through assistance program 93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance.
The Project Grant was awarded through grant opportunity State Opioid Response Grants.
Status
(Ongoing)
Last Modified 2/5/25
Period of Performance
9/30/24
Start Date
9/29/27
End Date
Funding Split
$4.0M
Federal Obligation
$0.0
Non-Federal Obligation
$4.0M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for H79TI087740
Transaction History
Modifications to H79TI087740
Additional Detail
Award ID FAIN
H79TI087740
SAI Number
H79TI087740-1053223780
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75SAMH SAMHSA DIVISION OF GRANTS MANAGEMENT
Funding Office
75MT00 SAMHSA CENTER FOR SUBSTANCE ABUSE TREATMENT
Awardee UEI
GSKXYGKGX6A4
Awardee CAGE
45VB5
Performance District
ND-00
Senators
John Hoeven
Kevin Cramer
Kevin Cramer
Modified: 2/5/25